Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 938425, 9 pages
http://dx.doi.org/10.1155/2013/938425
Research Article

Epimedium Flavonoids Counteract the Side Effects of Glucocorticoids on Hypothalamic-Pituitary-Adrenal Axis

1Key Laboratory of Cellular and Molecular Biology, Huashan Hospital, Fudan University, Shanghai 200040, China
2Department of Integrative Medicine, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China
3Department of Geriatrics, Huadong Hospital, Fudan University, Shanghai 200040, China
4Department of Perinatal Medicine, The Royal Women's Hospital, University of Melbourne, Parkville, VIC 3052, Australia
5School of Acupuncture, Massage and Rehabilitation, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
6Shanghai Institute of Geriatrics, Huadong Hospital, Fudan University, Shanghai 200040, China

Received 19 April 2013; Revised 10 August 2013; Accepted 19 August 2013

Academic Editor: Jenny M. Wilkinson

Copyright © 2013 Jianhua Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Hughes and M. M. Mehndiratta, “Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy,” Cochrane Database of Systematic Reviews, no. 8, Article ID CD002062, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Suzuki, “Current therapeutic strategy for multiple myeloma,” Japanese Journal of Clinical Oncology, vol. 43, no. 2, pp. 116–124, 2013. View at Publisher · View at Google Scholar
  3. B. M. Vayssière, S. Dupont, A. Choquart et al., “Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo,” Molecular Endocrinology, vol. 11, no. 9, pp. 1245–1255, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Resche-Rigon and H. Gronemeyer, “Therapeutic potential of selective modulators of nuclear receptor action,” Current Opinion in Chemical Biology, vol. 2, no. 4, pp. 501–507, 1998. View at Google Scholar · View at Scopus
  5. R. L. Hopkins and M. C. Leinung, “Exogenous Cushing's syndrome and glucocorticoid withdrawal,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 2, pp. 371–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Livanou, D. Ferriman, and V. H. James, “Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy,” The Lancet, vol. 2, no. 7521, pp. 856–859, 1967. View at Google Scholar · View at Scopus
  7. B. Richter, G. Neises, and C. Clar, “Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review,” Endocrinology and Metabolism Clinics of North America, vol. 31, no. 3, pp. 751–778, 2002. View at Publisher · View at Google Scholar
  8. M. Maes, A. van Gastel, H. Y. Meltzer, P. Cosyns, P. Blockx, and R. Desnyder, “Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression,” Psychoneuroendocrinology, vol. 21, no. 1, pp. 67–81, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. T. S. Huang, “Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone,” Metabolism, vol. 43, no. 5, pp. 544–548, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Dong, Z. Y. Shi, and Z. Y. Shen, “Investigation of treating steroids dependent asthmatic patients with kidney-tonifying herbs and high dose beclomethasone dipropionate aerosol,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 14, no. 8, pp. 458–461, 1994. View at Google Scholar · View at Scopus
  11. R. S. Pearson, J. H. Baylis, and H. C. Smellie, “Treatment of chronic asthma with prednisolone and the newer steroids,” British Medical Journal, vol. 1, no. 5222, pp. 315–319, 1961. View at Google Scholar · View at Scopus
  12. P. H. Henneman, D. M. Wang, J. W. Irwin, and W. S. Burrage, “Syndrome following abrupt cessation of prolonged cortisone therapy,” Journal of the American Medical Association, vol. 158, no. 5, pp. 384–386, 1955. View at Google Scholar · View at Scopus
  13. C. R. Jenkins and A. J. Woolcock, “Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study,” Thorax, vol. 43, no. 5, pp. 378–384, 1988. View at Google Scholar · View at Scopus
  14. S. J. Cameron, E. J. Cooper, and G. K. Crompton, “Substitution of beclomethasone aerosol for oral prednisolone in the treatment of chronic asthma,” British Medical Journal, vol. 4, no. 5886, pp. 205–207, 1973. View at Google Scholar · View at Scopus
  15. B. Wu, S. Yan, Z. Lin et al., “Metabonomic study on ageing: NMR-based investigation into rat urinary metabolites and the effect of the total flavone of epimedium,” Molecular BioSystems, vol. 4, no. 8, pp. 855–861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Knigge, “Adrenocortical response to stress in rats with lesions in hippocampus and amygdala,” Proceedings of the Society for Experimental Biology and Medicine, vol. 108, no. 1, pp. 18–21, 1961. View at Publisher · View at Google Scholar
  17. J. P. Herman, J. M. Mcklveen, M. B. Solomon, E. Carvalho-Netto, and B. Myers, “Neural regulation of the stress response: glucocorticoid feedback mechanisms,” Brazilian Journal of Medical and Biological Research, vol. 45, no. 4, pp. 292–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Feldman and N. Conforti, “Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity,” Neuroendocrinology, vol. 30, no. 1, pp. 52–55, 1980. View at Google Scholar · View at Scopus
  19. M. Quinn, Y. Ueno, H. Y. Pae et al., “Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 302, no. 1, pp. G182–G193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. G. G. Nussdorfer, “Cytophysiology of the adrenal cortex,” International Review of Cytology, vol. 98, pp. 1–405, 1986. View at Google Scholar · View at Scopus
  21. B. Lesniewska, K. W. Nowak, and L. K. Malendowicz, “Dexamethasone-induced adrenal cortex atrophy and recovery of the gland from partial, steroid-induced atrophy,” Experimental and Clinical Endocrinology, vol. 100, no. 3, pp. 133–139, 1992. View at Google Scholar · View at Scopus
  22. J. P. Dupouy, A. Chatelain, and M. Godaut, “Influences of heparin on ACTH distribution and immunoreactivity in plasma of the rat in vivo and in vitro studies,” Journal de Physiologie, vol. 76, no. 6, pp. 631–635, 1980. View at Google Scholar · View at Scopus
  23. G. P. Vinson, “Adrenocortical zonation and ACTH,” Microscopy Research and Technique, vol. 61, no. 3, pp. 227–239, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. F. Tait and S. A. Tait, “Recent perspectives on the history of the adrenal cortex. The Sir Henry Dale lecture for 1979,” Journal of Endocrinology, vol. 83, no. 1, pp. 3P–24P, 1979. View at Google Scholar · View at Scopus
  25. G. Zajicek, I. Ariel, and N. Arber, “The streaming adrenal cortex: direct evidence of centripetal migration of adrenocytes by estimation of cell turnover rate,” Journal of Endocrinology, vol. 111, no. 3, pp. 477–482, 1986. View at Google Scholar · View at Scopus
  26. F. Mitani, H. Suzuki, J.-I. Hata, T. Ogishima, H. Shimada, and Y. Ishimura, “A novel cell layer without corticosteroid-synthesizing enzymes in rat adrenal cortex: histochemical detection and possible physiological role,” Endocrinology, vol. 135, no. 1, pp. 431–438, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Mitani, K. Mukai, H. Miyamoto, M. Suematsu, and Y. Ishimura, “The undifferentiated cell zone is a stem cell zone in adult rat adrenal cortex,” Biochimica et Biophysica Acta, vol. 1619, no. 3, pp. 317–324, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. W. B. Ennen, B. K. Levay-Young, and W. C. Engeland, “Zone-specific cell proliferation during adrenocortical regeneration after enucleation in rats,” American Journal of Physiology: Endocrinology and Metabolism, vol. 289, no. 5, pp. E883–E891, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Thomas, S. R. Northrup, and P. J. Hornsby, “Adrenocortical tissue formed by transplantation of normal clones of bovine adrenocortical cells in scid mice replaces the essential functions of the animals' adrenal glands,” Nature Medicine, vol. 3, no. 9, pp. 978–983, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. T. M. Taki and P. A. Nickerson, “Differentiation and proliferation of adrenocortical cells during the early stages of regeneration,” Laboratory Investigation, vol. 53, no. 1, pp. 91–100, 1985. View at Google Scholar · View at Scopus
  31. A. H. Wyllie, J. F. R. Kerr, I. A. M. Macaskill, and A. R. Currie, “Adrenocortical cell deletion: the role of ACTH,” Journal of Pathology, vol. 111, no. 2, pp. 85–94, 1973. View at Google Scholar · View at Scopus
  32. D. Pignatelli, J. Ferreira, P. Vendeira, M. C. Magalhães, and G. P. Vinson, “Proliferation of capsular stem cells induced by ACTH in the rat adrenal cortex,” Endocrine Research, vol. 28, no. 4, pp. 683–691, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. A. S. Belloni, G. Mazzocchi, V. Meneghelli, and G. G. Nussdorfer, “Cytogenesis in the rat adrenal cortex: evidence for an ACTH-induced centripetal cell migration from the zona glomerulosa,” Archives d'Anatomie, d'Histologie et d'Embryologie, vol. 61, pp. 195–205, 1978. View at Google Scholar · View at Scopus
  34. E. J. Whitworth, O. Kosti, D. Renshaw, and J. P. Hinson, “Adrenal neuropeptides: regulation and interaction with ACTH and other adrenal regulators,” Microscopy Research and Technique, vol. 61, no. 3, pp. 259–267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M. T. Pham-Huu-Trung, J. M. Villette, A. Bogyo, J. M. Duclos, J. Fiet, and M. Binoux, “Effects of insulin-like growth factor I (IGF-I) on enzymatic activity in human adrenocortical cells. Interactions with ACTH,” Journal of Steroid Biochemistry and Molecular Biology, vol. 39, no. 6, pp. 903–909, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Palmieri, D. Roberts-Clark, A. Assadi-Sabet et al., “Fibrolast growth factor 7, secreted by breast fibroblasts, is an interleukin-1β-induced paracrine growth factor for human breast cells,” Journal of Endocrinology, vol. 177, no. 1, pp. 65–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. G. P. Rossi, P. G. Andreis, S. Colonna et al., “Endothelin-1[1-31]: a novel autocrine-paracrine regulator of human adrenal cortex secretion and growth,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 1, pp. 322–328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. G. G. Nussdorfer, R. Spinazzi, and G. Mazzocchi, “Cholecystokinin and adrenal-cortex secretion,” Vitamins and Hormones, vol. 71, pp. 433–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Ziolkowska, K. Budzynska, M. Trejter, C. Tortorella, A. S. Belloni, and L. K. Malendowicz, “Effects of adrenomedullin and its fragment 22-52 on basal and ACTH-stimulated secretion of cultured rat adrenocortical cells,” International Journal of Molecular Medicine, vol. 11, no. 5, pp. 613–615, 2003. View at Google Scholar · View at Scopus
  40. S. R. Bornstein, H. Rutkowski, and I. Vrezas, “Cytokines and steroidogenesis,” Molecular and Cellular Endocrinology, vol. 215, no. 1-2, pp. 135–141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. M. M. Weber, P. Simmler, C. Fottner, and D. Engelhardt, “Insulin-like growth factor II (IGF-II) is more potent than IGF-I in stimulating cortisol secretion from cultured bovine adrenocortical cells: interaction with the IGF-I receptor and IGF-binding proteins,” Endocrinology, vol. 136, no. 9, pp. 3714–3720, 1995. View at Google Scholar · View at Scopus
  42. R. P. A. Rooman, G. Kuijpers, R. Gresnigt, R. Bloemen, J. G. Koster, and S. C. van Buul-Offers, “Dexamethasone differentially inhibits thyroxine- or growth hormone-induced body and organ growth of snell dwarf mice,” Endocrinology, vol. 144, no. 6, pp. 2553–2558, 2003. View at Publisher · View at Google Scholar · View at Scopus